Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-008429
Filing Date
2020-03-16
Accepted
2020-03-16 16:02:22
Documents
1
Period of Report
2020-03-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7583
  Complete submission text file 0000899243-20-008429.txt   8903
Mailing Address 103 JFK PARKWAY SHORT HILLS NJ 07078
Business Address
Konidaris Tasos (Reporting) CIK: 0001320982 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38485 | Film No.: 20717051

Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Issuer) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations